Physician profile
Scott Crater
NPI 1992894414
$726.75
in general payments reported to CMS, 2019-2025
8 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.28 · 2022: $88.90 · 2023: $199 · 2024: $226 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $355.22 | 2021-2025 | Winlevi, Absorica Ld, Ilumya |
| Biofrontera INC. | $122.21 | 2025 | |
| Janssen Biotech, INC. | $78.63 | 2021-2024 | Simponi Aria, Stelara, Simponi |
| Lilly USA, LLC | $50.13 | 2023-2024 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $35.58 | 2022-2025 | |
| Galderma Laboratories, L.P. | $32.55 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $31.52 | 2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $20.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Crater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.